UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000006095
Receipt No. R000007213
Scientific Title A phase I study of irinotecan for previously treated lung cancer patients with UGT1A1*28 or *6 polymorphism
Date of disclosure of the study information 2011/08/01
Last modified on 2021/02/17 20:24:05

No. Disposal Last modified on Item of update
1 Insert 2011/08/01 22:51:36
2 Update 2011/08/23 07:27:18 UMIN ID1
3 Update 2012/08/08 09:13:40 Organization1
Address1
Tel1
Email1
4 Update 2014/09/09 10:10:26 TEL
Email
TEL
Email
Organization
5 Update 2014/09/09 10:10:53 Recruitment status
6 Update 2021/02/17 20:00:48 Key exclusion criteria
7 Update 2021/02/17 20:06:18 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Name of primary sponsor
Organization
Organization
Organization
Address
Address
Tel
Email
8 Update 2021/02/17 20:13:05 Recruitment status
Date of IRB
Last follow-up date
9 Update 2021/02/17 20:23:21 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
10 Update 2021/02/17 20:24:05 Results
Outcome measures


Contact us.